Loading...
Beyond abiraterone: New hormonal therapies for metastatic castration-resistant prostate cancer
Prostate cancer is a heterogeneous disease where the previous concept of “hormone resistance” has been changed by a new generation of hormonal therapies that have proven efficacy in the castration-resistant setting. The fact is that androgens play a crucial role in the whole clinical course of prost...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Landes Bioscience
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3928129/ https://ncbi.nlm.nih.gov/pubmed/24100689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.26724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|